Management of Complications of BCMA-Directed Therapy in Relapsed Multiple Myeloma: A Focused Review

被引：0
|
作者：
Khanam, Razwana [1 ]
Batool, Saba [2 ]
Najmuddin, Mohammed Musa [3 ]
Usman, Rana [4 ]
Kuriakose, Kiran [5 ]
Ahmed, Arooj [6 ]
Rehman, Mohammad Ebad Ur [7 ]
Roksana, Zinath [8 ]
Anwer, Faiz [9 ]
机构：
[1] Baystate Med Ctr, Springfield, MA USA
[2] Unity Point Methodist Hosp, Peoria, IL USA
[3] Wright Ctr Grad Med Educ, Scranton, PA USA
[4] Univ Tennessee, Hlth Ctr, Memphis, TN USA
[5] UPMC Mercy, Pittsburgh, PA USA
[6] Cleveland Clin, Cleveland, OH 44106 USA
[7] Rawalpindi Med Univ, Rawalpindi, Pakistan
[8] Feni Sadar Hosp, Feni, Bangladesh
[9] Cleveland Clin, Dept Hematol & Med Oncol, Taussig Canc Inst, Cleveland, OH 44106 USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-164871
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：12494 / 12495
页数：2
相关论文
共 50 条
  • [21] Antigen escape as a shared mechanism of resistance to BCMA-directed therapies in multiple myeloma
    Firestone, Ross S.
    Socci, Nicholas D.
    Shekarkhand, Tala
    Zhu, Menglei
    Qin, Wei Ge
    Hultcrantz, Malin
    Mailankody, Sham
    Tan, Carlyn Rose
    Korde, Neha
    Lesokhin, Alexander M.
    Hassoun, Hani
    Shah, Urvi
    Maclachlan, Kylee H.
    Rajeeve, Sridevi
    Landau, Heather J.
    Scordo, Michael
    Shah, Gunjan L.
    Lahoud, Oscar B.
    Giralt, Sergio
    Murata, Kazunori
    Usmani, Saad Z.
    Chung, David J.
    BLOOD, 2024, 144 (04) : 402 - 407
  • [22] BCMA-directed therapy, new treatments in the myeloma toolbox, and how to use them
    Rees, Matthew James
    Kumar, Shaji
    LEUKEMIA & LYMPHOMA, 2024, 65 (03) : 287 - 300
  • [23] SWASTH: Phase 1/2 Study of Ribrecabtagene Autoleucel, a BCMA-Directed CAR-T Cell Therapy, in Relapsed-Refractory Multiple Myeloma
    Menon, Hari
    Bharagava, Rahul
    Lokireddy, Padmaja
    Narayanan, Prasad
    Nataraj, K. S.
    Kumar, Akhil
    Mandavia, Divyesh
    Ramachandra, Murali
    Mathews, Vikram
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S65 - S65
  • [24] Impact of Clonal Hematopoiesis on Clinical Outcomes to BCMA-Directed CAR T-Cell Therapy in Multiple Myeloma
    Gustine, Joshua
    Branagan, Andrew
    Cirstea, Diana
    Rexha, Farah
    Han, Ryan
    Yee, Andrew
    Frigault, Matthew
    Raje, Noopur
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S4 - S5
  • [25] PD-1 Inhibitor Combinations As Salvage Therapy for Relapsed/Refractory Multiple Myeloma (MM) Patients Progressing after Bcma-Directed CAR T Cells
    Bernabei, Luca
    Garfall, Alfred L.
    Melenhorst, J. Joseph
    Lacey, Simon F.
    Stadtmauer, Edward A.
    Vogl, Dan T.
    Gonzalez, Vanessa
    Plesa, Gabriela
    Young, Regina M.
    Waxman, Adam
    Levine, Bruce L.
    June, Carl H.
    Milone, Michael C.
    Cohen, Adam D.
    BLOOD, 2018, 132
  • [26] Salvage therapies including retreatment with BCMA-directed approaches after BCMA CAR-T relapses for multiple myeloma
    Reyes, Kevin R.
    Liu, Yen-Chun
    Huang, Chiung-Yu
    Banerjee, Rahul
    Martin, Thomas
    Wong, Sandy W.
    Wolf, Jeffrey L.
    Arora, Shagun
    Shah, Nina
    Chari, Ajai
    Chung, Alfred
    BLOOD ADVANCES, 2024, 8 (09) : 2207 - 2216
  • [27] Outcomes Multiple Myeloma Patients Progressing after BCMA-Directed Chimeric Antigen Receptor T Cell (CART) Therapy
    Soomro, Mohammad Ahsen
    Atrash, Shebli
    Rashid, Aliya
    Wesson, William
    Hashmi, Hamza
    Afrough, Aimaz
    Skikne, Barry S.
    Lutfi, Forat
    Mushtaq, Muhammad Umair
    Abdallah, Al-Ola
    Ahmed, Nausheen
    BLOOD, 2023, 142
  • [28] Alternative Lymphodepletion Strategies Lead to Similar Response Rates and Toxicities in Standard-of-Care BCMA-Directed CAR-T Therapy in Relapsed Refractory Multiple Myeloma
    Midha, Shonali
    Gurumurthi, Ashwath
    Costello, Patrick
    Redd, Robert A.
    Freeman, Ciara Louise L.
    Castaneda, Omar
    Gonzalez, Rebecca
    Ionescu, Filip
    Gaballa, Mahmoud
    Kalariya, Nilesh
    Khouri, Jack
    Dima, Danai
    Kocoglu, Mehmet H.
    Sborov, Douglas
    Wagner, Charlotte B.
    Atrash, Shebli
    Voorhees, Peter M.
    Hashmi, Hamza
    Davis, James A.
    Forsberg, Peter A.
    McGuirk, Joseph P.
    Shune, Leyla
    Herr, Megan
    Reshef, Ran
    Lin, Yi
    Htut, Myo
    Martin, Thomas
    Sidana, Surbhi
    Hansen, Doris K.
    Nadeem, Omar
    Patel, Krina K.
    BLOOD, 2023, 142
  • [29] Characteristics of infections after BCMA-directed CAR T-cell therapy for multiple myeloma: a real-world analysis
    Richardson, Tim
    Schuette, Daniel
    Kobbe, Guido
    Baermann, Ben-Niklas
    Holderried, Tobias A. W.
    Schmitz, Friederike
    Crysandt, Martina
    Hallek, Michael
    Scheid, Christoph
    Holtick, Udo
    Cornely, Oliver A.
    Stemler, Jannik
    Mellinghoff, Sibylle C.
    BLOOD ADVANCES, 2025, 9 (06) : 1370 - 1375
  • [30] Phase I Study of a BCMA-Directed CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma Manufactured in <3 Days Using the High-Performance Platform
    Liu, Hui
    Wang, Ting
    Yang, Yazi
    Feng, Ru
    Li, Jiangtao
    Zhang, Chunli
    Bai, Jiefei
    Ding, Yanping
    Liu, Guanghua
    Wu, Fei
    Lu, Xinan
    Li, Jian
    He, Ting
    BLOOD, 2022, 140 : 10307 - 10308
12345